The European surveillance activities EARSS and ESAC in the context of ABS International.
Development of resistance obstructs the successful use of antimicrobial drugs, since shortly after each and every introduction of a new antibiotic resistant pathogens have emerged. The hope of being able to reverse or at least slow down the occurrence of antibiotic resistance has led to a number of actions and initiatives. The project "ABS International - Implementing antibiotic strategies for appropriate use of antibiotics in hospitals in member states of the European Union", together with the European Antimicrobial Resistance Surveillance System (EARSS) and the European Surveillance on Antimicrobial Consumption (ESAC), covers a large proportion of possible actions against antibiotic resistance. The data generated by EARSS and ESAC are an essential prerequisite for targeted interventions to cope with the problem of antibiotic resistance. The project ABS International constitutes an impressive initiative to optimize the situation in hospitals in nine European member states.
Metz-Gercek
Sigrid
S
Department of Hygiene, Microbiology and Tropical Medicine, National Reference Center for Nosocomial Infections and Antibiotic Resistance, Elisabethinen Hospital Linz, Austria. earss@gmx.at
Mittermayer
Helmut
H
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000890:Anti-Infective Agents; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control*; D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control*; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D004352:Drug Resistance, Microbial; D005062:European Union / Q000458:organization & administration*; D006078:Government Programs / Q000458:organization & administration*; D006293:Health Promotion / Q000458:organization & administration; D006801:Humans; D011159:Population Surveillance / Q000379:methods*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents